Article

REGEN-COV protects against viral escape in preclinical and human studies

2021-03-11

Abstract excerpt

<h4>Summary</h4> Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. As rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment emergent resistance. To this end, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dee46797-3275-5c3b-80f5-3d4bde7582ab
DOI: 10.1101/2021.03.10.434834

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

REGEN-COV protects against viral escape in preclinical and human studiesDOI 10.1101/2021.03.10.434834Read

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.Semantic proximity Read

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation.Semantic proximity Read

Broadly neutralizing antibodies against COVID-19Semantic proximity Read

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernSemantic proximity Read

A Comprehensive Account of SARS-CoV-2 Genome structure, Incurred mutations, Lineages and COVID-19 Vaccination ProgramSemantic proximity Read

Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralizationSemantic proximity Read

Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variantsSemantic proximity Read

Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsSemantic proximity Read

A cocktail of SARS-CoV-2 spike stem helix domain and receptor binding domain human monoclonal antibodies prevent the emerge of viral escape mutantsSemantic proximity Read

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational lockingSemantic proximity Read

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studySemantic proximity Read